...Barr Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and marketing of pharmaceutical products. The company operates in two segments, Generic Pharmaceuticals and Proprietary Pharmaceuticals. The Generic Pharmaceuticals segment markets approximately ### dosage forms and strengths of approximately ## different generic pharmaceutical products, including ## oral contraceptive products, representing the category of its generic portfolio. It manufactures products in the form of tablets, capsules, and powder. The Proprietary Pharmaceuticals segment markets ## proprietary pharmaceutical products, focusing in the female healthcare arena, including oral contraceptive and hormone therapy products; oncology; cardiovascular; anti -infective; and psychotherapeutic pharmaceuticals. These products include Aygestin, for amenorrhea; Cenestin line of hormone therapy products; Diamox and Sequels, for glaucoma; Loestrin/Loestrin Fe, and Nordette, for oral...

Source: LIFE SCIENCE ANALYTICS
Company: BARR PHARMACEUTICALS INC
Geographic Regions: MID-ATLANTIC/MIDDLE ATLANTIC REGION, NORTH AMERICA, NEW YORK (STATE OF), UNITED STATES OF AMERICA
Non-Billable Page Numbers: 87

Enter the keyword(s) which you would like to search for within this document and click "Search"

 

 TF Market Research
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.